During the past decade, Torbay and South Devon Nhs Foundation Trust conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Torbay and South Devon Nhs Foundation Trust" #1 sponsor was "Merck Sharp & Dohme LLC" with 3 trials, followed by "University of Leeds" with 2 trials sponsored, "Gilead Sciences" with 1 trials sponsored, "Guy's and St Thomas' NHS Foundation Trust" with 1 trials sponsored and "Heartfelt Technologies" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Torbay and South Devon Nhs Foundation Trust" #1 collaborator was "Torbay and South Devon NHS Foundation Trust" with 2 trials as a collaborator, "University of Oxford" with 2 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "King's College London" with 1 trials as a collaborator and "Medical Research Council" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Torbay and South Devon Nhs Foundation Trust" are "Prostatic Neoplasms" (3 trials), "Arthritis, Rheumatoid" (2 trials), "Giant Cell Arteritis" (2 trials), "ANCA Associated Vasculitis" (1 trials) and "COPD" (1 trials). Many other conditions were trialed in "Torbay and South Devon Nhs Foundation Trust" in a lesser frequency.

Most popular intervention types in "Torbay and South Devon Nhs Foundation Trust" are "Drug" (6 trials), "Biological" (3 trials), "Device" (2 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (3 trials), "Placebo" (3 trials), "Enzalutamide" (2 trials), "Prednisone" (2 trials) and "Abiraterone acetate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Torbay and South Devon Nhs Foundation Trust" are 10 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Torbay and South Devon Nhs Foundation Trust". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Torbay and South Devon Nhs Foundation Trust, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Torbay and South Devon Nhs Foundation Trust, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

Torbay and South Devon Nhs Foundation Trust has several departments that took part in Clinical trials: "Torbay Hospital; Oncology Department" - 5 trials, "Torbay Hospital; Dept of Rhematology" - 2 trials